UA110795C2 - Method of treatment of pancreatic cancer - Google Patents

Method of treatment of pancreatic cancer

Info

Publication number
UA110795C2
UA110795C2 UAA201300190A UAA201300190A UA110795C2 UA 110795 C2 UA110795 C2 UA 110795C2 UA A201300190 A UAA201300190 A UA A201300190A UA A201300190 A UAA201300190 A UA A201300190A UA 110795 C2 UA110795 C2 UA 110795C2
Authority
UA
Ukraine
Prior art keywords
pancreatic cancer
treatment
malignant pancreatic
taxanes
nanoparticles
Prior art date
Application number
UAA201300190A
Other languages
Ukrainian (uk)
Inventor
Нейл П. Дісей
Патрік Соон-Шионг
Original Assignee
Абраксіс Байосайєнс, Елелсі
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Абраксіс Байосайєнс, Елелсі filed Critical Абраксіс Байосайєнс, Елелсі
Priority claimed from PCT/US2011/037462 external-priority patent/WO2011153010A1/en
Publication of UA110795C2 publication Critical patent/UA110795C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід стосується способу лікування злоякісної пухлини підшлункової залози у індивіда, який раніше піддавався лікуванню в зв'язку зі злоякісною пухлиною підшлункової залози (наприклад, впливу терапії на основі гемцитабіну), шляхом введення композиції, яка містить наночастинки, що включають в себе таксан і альбумін, та іншого терапевтичного засобу.The invention relates to a method of treating a malignant pancreatic cancer in an individual who has previously been treated for a malignant pancreatic tumor (eg, exposure to gemcitabine therapy) by administering a composition comprising alpha nanoparticles and taxanes and other therapeutic agents.

UAA201300190A 2010-06-04 2011-05-20 Method of treatment of pancreatic cancer UA110795C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35184610P 2010-06-04 2010-06-04
PCT/US2011/037462 WO2011153010A1 (en) 2010-06-04 2011-05-20 Methods of treatment of pancreatic cancer

Publications (1)

Publication Number Publication Date
UA110795C2 true UA110795C2 (en) 2016-02-25

Family

ID=55700623

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201300190A UA110795C2 (en) 2010-06-04 2011-05-20 Method of treatment of pancreatic cancer

Country Status (1)

Country Link
UA (1) UA110795C2 (en)

Similar Documents

Publication Publication Date Title
MY162903A (en) Methods of treatment of pancreatic cancer
MX2021013830A (en) Ezh2 inhibitors for treating lymphoma.
MX2019010601A (en) Combination therapy for treating cancer.
CY1118216T1 (en) METHODS OF CANCER EDUCATION
IN2012DN02018A (en)
MY166014A (en) Combination therapy methods for treating proliferative diseases
MX2016007351A (en) Combination therapy for treating cancer.
NZ738929A (en) Methods of treating solid tumors using nanoparticle mtor inhibitor combination therapy
NZ630367A (en) Methods of treatment of pediatric solid tumor
NZ602635A (en) Methods of enhancing drug delivery and effectiveness of therapeutic agents
MX346861B (en) Methods of treatment of hepatocellular carcinoma.
NZ593343A (en) Combination cancer treatment conprising Abraxane and an inflamatory inhibitor
UA109271C2 (en) Combination of phytocannabinoids and temosolamide for treating glioma
EA201391286A1 (en) TREATMENT OF SOLID TUMORS
CY1111547T1 (en) COMBINATION ZD6474 AND PERMETRIC
MX2020001727A (en) Combination therapy.
MX2019003694A (en) Methods of treating biliary tract cancer.
MY160406A (en) Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
MX2018010223A (en) Combination therapy for treatment of ovarian cancer.
NO20064754L (en) combination therapy
MX2017013666A (en) Anti-fugetactic agent and immunotherapy agent combination therapy and compositions for the treatment of cancer.
UA110795C2 (en) Method of treatment of pancreatic cancer
EA202190294A1 (en) COMBINATION THERAPY FOR CANCER TREATMENT
MX2021001084A (en) Combination therapy for treating cancer.
EA201491836A1 (en) METHODS OF CANCER TREATMENT USING PI3K INHIBITOR AND MEK INHIBITOR